Sign In | Make a payment | Links
OU Stephenson Cancer Center, Oklahoma City, OK More Information will be posted soon.
Tuesday, June 14, 2016. 1–2 p.m. Eastern 12–1 p.m. Central 11 a.m.–12 p.m. Mountain 10–11 a.m. Pacific Earn 1 Credit Register Here Click Here to learn more.
Medicare Policy Clarified for Prolonged Drug and Biological Infusions Started Incident to a Physician’s Service Using an External Pump
On April 25, 2016, the U. S. Food and Drug Administration approved cabozantinib (CABOMETYX, Exelixis, Inc.) for the treatment of advanced renal cell carcinoma in patients who have received prior anti-angiogenic therapy.